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infections. Although we did not 
conduct a case–control study, these 
fi ndings also support the results of 
other studies that previously reported 
the demographic characteristics of 
patients with pandemic infl uenza 
infections and the risk factors for 
severe or fatal pandemic infl uenza 
infections (3,4), especially with 
respect to obesity (5).
Evaluation of tissues collected 
during autopsy from patients with 
a suspected infectious process can 
provide an etiologic diagnosis that 
was not available from routine 
premortem and postmortem testing. 
Other etiologic agents detected in 
this study included reportable disease 
agents (e.g., Rickettsia rickettsii, 
Legionella pneumophila, dengue 
virus), vaccine-preventable diseases 
(e.g., pneumococcal, meningococcal 
diseases), and zoonotic agents 
(Leptospira and Capnocytophaga 
spp.). These fi ndings underscore the 
need for autopsies for diagnosing 
fatal infectious diseases (6). They 
also confi rm the need for coordinated 
surveillance programs that identify 
deaths potentially attributable to 
infectious causes, including the 
unexplained deaths program (7) and 
medical examiner infectious diseases 
death surveillance program (8). 
Partnerships of medical examiners 
and pathologists with local, state, and 
federal public health departments are 
crucial for detecting and monitoring 
pandemic diseases and for assessing 
the scope and magnitude of infectious 
agents that continuously affect human 
populations (9). These infections often 
result in sudden or unexplained death; 
thus, a standardized approach to death 
investigations is recommended.
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To the Editor: In 2010, the 
city of Ngaoundéré in Cameroon 
experienced its fi rst reported epidemic 
of meningococcal meningitis. 
Ngaoundéré, with an estimated 
population of 180,000, is the main city 
in the Adamaoua region in northern 
Cameroon. The 2 northernmost regions 
of Cameroon, North and Far North, 
are considered to belong to the African 
meningitis belt (1) and are periodically 
affected by meningococcal meningitis 
outbreaks. However, the Adamaoua 
region had been spared because of its 
altitude, latitude, and low population 
density in comparison with the North 
and Far North regions. Fewer than 10 
sporadic cases have been reported in 
the Adamaoua region every year.
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During February–April 2010, 
a total of 126 cases of meningitis 
(70 cases/100,000 inhabitants) were 
reported in the Adamaoua region. Of 
the 126 cases, 34 were confi rmed by 
identifi cation of Neisseria meningitidis 
serogroup A in cerebrospinal fl uid 
(CSF) samples, 46 cases were apparent 
meningitis in which the patients had 
turbid CSF, and 46 were clinical cases 
diagnosed in an epidemic context. The 
male:female ratio of the patients was 
2.7:1. The mean age of patients was 19 
years, and median was 17 years.
CSF specimens from 34 patients 
were sent to the Centre Pasteur du 
Cameroun in Garoua for testing. 
Laboratory procedures included 
assessing CSF turbidity, Gram 
staining, searching for soluble 
capsular antigens by using the 
Pastorex latex agglutination kit (Bio-
Rad, Hercules, CA, USA), and testing 
by the dipstick rapid diagnostic test 
for N. meningitidis serogroups A, C, 
W135, and Y (provided by the Centre 
de Recherche Médicale et Sanitaire, 
Niamey, Niger).
All 34 specimens were positive 
for serogroup A by agglutination, rapid 
test, or both. CSF specimens were 
cultured on blood agar and chocolate 
agar supplemented with PolyViteX 
(bioMérieux, Marcy-l’Etoile, 
France) and incubated at 37°C in an 
atmosphere of 5% CO2. Susceptibility 
to antimicrobial drugs was tested 
according to the recommendations 
of the Antibiogram Committee of 
the French Society for Microbiology 
(www.sfm.asso.fr). An isolate of N. 
meningitidis was sent to the World 
Health Organization Collaborating 
Centre for Reference and Research 
on Meningococci in Oslo, Norway, 
for molecular analyses, as described 
(www.neisseria.org). The result was 
that the isolate, a N. meningitidis 
serogroup A clone of sequence type 
7, was susceptible to β-lactams and 
chloramphenicol but resistant to 
trimethoprim/sulfamethoxazole.
This epidemic occurred in an area 
where the mean annual rainfall for the 
past 30 years was 1,460 mm (Agency 
for Aerial Navigation Safety in Africa 
and Madagascar, unpub. data). This 
value should exclude Ngaoundéré 
from the African meningitis belt, for 
which the southern limit of annual 
rainfall was classically considered to 
be the 1,100-mm isohyet (Figure).
This epidemic at the border of 
the African meningitis belt raises the 
question of the belt limitation and its 
potential expansion southward. These 
topics should be addressed through 
active and standardized surveillance 
in countries such as Cameroon, which 
are not entirely included in the belt 
(2,3).
This meningitis epidemic has 2 
other noteworthy characteristics. First, 
80 (63%) of 126 suspected cases had 
a lumbar puncture performed at the 
Ngaoundéré Regional Hospital or at 
the Norwegian hospital. With the help 
of the laboratory, an increasing number 
of cases of meningitis in Cameroon 
are confi rmed cases (4). Second, 
the etiologic agent was serogroup A 
meningococcus, a serogroup that had 
not been identifi ed in north Cameroon 
since 2006 (5) but that had been 
isolated previously (6) and in south 
Cameroon (7).
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Figure. Northern regions of Cameroon with mean annual rainfall. Maroua is at the 800 mm 
isohyet line, Garoua at 1,006 mm, and Ngaoundéré at 1,460 mm. Estimate for Maroua 
is by the Agency for Aerial Navigation Safety in Africa and Madagascar; recorded rainfall 
for Garoua and Ngaoundéré are by the Agency for Aerial Navigation Safety in Africa and 
Madagascar. Eq. Guinea, Equatorial Guinea.
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To the Editor: Infection with 
Shigella spp. is a major cause of 
foodborne diseases, which have 
increased considerably during the past 
decades, but only a small fraction of 
cases are reported (1). S. dysenteriae 
and S. fl exneri are the predominant 
species in the tropics; clinically, S. 
dysenteriae serotype 1 is associated 
with severe disease, large outbreaks, 
or epidemics. S. sonnei occurs more 
frequently in industrialized than in 
developing countries and causes 
milder illness than S. dysenteriae 
and S. fl exneri. However, occasional 
foodborne outbreaks by antimicrobial 
drug–resistant S. sonnei have been 
reported from the United States, Japan, 
and European countries, mostly among 
children (2–5). During recent years, in 
Thailand, Vietnam, and Sri Lanka, the 
predominant species has shifted from 
S. fl exneri to S. sonnei, a phenomenon 
possibly linked with country’s level 
of development (6,7). As a result, 
S. sonnei outbreaks are also being 
reported from developing countries 
(8). In India, the scenario differed 
somewhat. Devastating outbreaks of 
dysentery by multidrug-resistant S. 
dysenteriae type 1, with high case-
fatality rates, affected major parts of 
the country during 1984–1985 (9). 
After a gap of 18 years, during 2002–
2003, S. dysenteriae type 1 with an 
altered antimicrobial drug resistance 
pattern (100% fl uoroquinolone 
resistance) reemerged, causing 
several dysentery outbreaks in West 
Bengal (10). Although S. fl exneri 
was the major species, since 2005, 
S. dysenteriae type 1 has not been 
isolated (9).
We report 2 foodborne outbreaks 
of S. sonnei in India, 1 each from 
Kerala (southern part) in February 
2009 and Maharashtra (western part) 
in February 2010, which support 
extension of S. sonnei into India. The 
outbreak isolates were characterized 
by antimicrobial drug resistance 
and plasmid and pulsed-fi eld gel 
electrophoresis profi les.
On February 1, 2009, >300 
persons (age range 2–70 years) 
attended a marriage party at 
Thiruvananthapuram, Kerala, where 
they were served local food made of 
rice, lentils, milk, and water. Within 
12 hours after eating, ≈60% of 
persons had onset of acute diarrhea, 
vomiting, and abdominal pain and 
were admitted to local village or 
district hospitals or the nearest 
government general hospital for 
treatment. Illness was more severe in 
children; because of clinical severity, 
10 children (<10 years of age) were 
admitted to a referral hospital for 
children in Thiruvananthapuram. 
One child (7 years of age) was 
moved to the pediatric intensive care 
unit because of altered sensorium 
and drowsiness and was treated 
with intravenous ceftriaxone and 
metronidazole. Others were treated 
with oral cefotaxime until recovery 
and were discharged. Fecal samples 
from 15 patients were processed at 
the local public health laboratory 
for enteric pathogens; 9 (60%) of 
15 samples yielded S. sonnei as 
the sole pathogen. On microscopic 
examination, 12 (80%) samples had 
erythrocytes.
The second outbreak occurred 
on February 11, 2010, at Kolhapur, 
Maharashtra, among day laborers 
and their family members who had 
eaten in 1 madrasa (religious place). 
Approximately 150 persons reported 
diarrhea, vomiting, abdominal pain, 
and fever. They were admitted to 
the Government Medical College, 
Kolhapur, and treated with intravenous 
fl uid (lactated Ringer’s solution), oral 
rehydration solution, intravenous 
ceftriaxone, and metronidazole. 
All patients were discharged after 
complete recovery. S. sonnei was 
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